Biopharmaceutical company utilizing TransCon technology to create long-acting therapies for rare diseases.
Werbung
Werbung
RASND
Ascendis Pharma A/S rStock
244.42
19. Sept., 03:47 UTC
Über
Info & Links
Webseite
Verträge
- arbitrum-one:0xa1b…2b3ac
- morph-l2:0xa47…ea778
Weiterlesen
Daten von